Pharma Journalist 9038 posts 0 comments

Telix Pharmaceuticals Limited announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited (‘China Grand…
Read More...

Biogen and Eisai, Co., Ltd. announced that the European Medicines Agency (EMA) has confirmed it has accepted for review, following a standard timetable, the Marketing Authorization…
Read More...

Sanofi and Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of life-threatening…
Read More...

SMi Reports: speaker session with Bjørg Kaae Hunter, Department Manager, RA CMC & Device, Novo Nordisk at Pre-filled Syringes and Injectable Drug Devices Conference 2021. Now in…
Read More...

SMi Reports: Registration is open for Europe’s only Parallel Trade virtual conference: online access only, taking place 22nd – 23rd March as a virtual conference. In light of on-going…
Read More...

Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients with…
Read More...

Protagonist Therapeutics, Inc. announced that two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech, Inc., have been…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the…
Read More...

AbCellera and Kodiak Sciences Inc. announced a new partnership to generate therapeutic antibody candidates in ophthalmology. Following a previously successful collaboration, AbCellera…
Read More...

AbbVie announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients…
Read More...